Latest News & Updates
Breaking News
1 hour ago
Simantini Singh Deo
Other trending news you may like to read
Oncolytics Biotech Receives FDA Fast Track Designation For Pelareorep In Advanced Anal Cancer
Oncolytics Biotech receives FDA Fast Track designation for pelareorep plus a checkpoint inhibitor in advanced, previously treated squamous cell anal cancer.
Simantini Singh Deo
Cosmos Health Expands Pharma Cell Partnership To Boost Sky Premium Life Distribution In Albania
Cosmos Health expands its Pharma Cell partnership, projecting over 54,000 annual units of Sky Premium Life supplements distributed across Albania.
Simantini Singh Deo
Neuronetics Appoints Nir Naor As Chief Financial Officer To Strengthen Growth Strategy
Neuronetics appoints Nir Naor as CFO effective July 23, 2026, while promoting Cory Anderson to EVP of Greenbrook as Chief Legal Officer Andrew Macan departs.
Simantini Singh Deo
Telix Doses First Patient In Phase 3 LUTEON Trial For Kidney Cancer Therapy TLX250-Tx
Telix doses the first patient in its Phase 3 LUTEON trial of TLX250-Tx, a CAIX-targeted radiopharmaceutical for relapsed clear cell renal cell carcinoma.
Simantini Singh Deo
